Int J Med Sci 2010; 7(4):191-196. doi:10.7150/ijms.7.191 This issue Cite

Research Paper

Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey

Davran Çiçek1, Hasan Pekdemir2, Nihat Kalay3, Süleyman Binici4, Hakan Altay4, Haldun Müderrisoğlu5

1. Başkent University School of Medicine, Department of Cardiology, Antalya, Turkey;
2. İnönü University School of Medicine, Department of Cardiology, Malatya, Turkey;
3. Erciyes University School of Medicine, Department of Cardiology, Kayseri, Turkey;
4. Başkent University School of Medicine, Department of Cardiology, Adana, Turkey;
5. Başkent University School of Medicine, Department of Cardiology, Ankara, Turkey

Citation:
Çiçek D, Pekdemir H, Kalay N, Binici S, Altay H, Müderrisoğlu H. Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey. Int J Med Sci 2010; 7(4):191-196. doi:10.7150/ijms.7.191. https://www.medsci.org/v07p0191.htm
Other styles

File import instruction

Abstract

Background: The efficacy of drug-eluting stents has been shown in randomized trials, but some controversy exists regarding which stent sirolimus-eluting or paclitaxel-eluting is more effective in unselected Turkish patients. Therefore, we investigated the clinical outcomes of patients who were treated with one type of these drug-eluting stents in the real world.

Methods: We created a registry and prospectively analyzed data on a consecutive series of all patients who presented to our institution with symptomatic coronary artery disease between February 2005 and March 2007 and who were treated with the sirolimus- or the paclitaxel-eluting stent. The follow-up period after stent implantation was approximately 24 months. The primary end point was a major cardiac event, and the secondary end point was stent thrombosis. Informed consent was obtained from all subjects, and the study protocol was approved by the local ethical committee.

Results: In total, 204 patients were treated with either the sirolimus-eluting stent (n = 103) or the paclitaxel-eluting stent (n = 101). The lesions in the 2 arms of the study were treated similarly by conventional technique. At 24-month follow-up, patients who received the paclitaxel-eluting stent showed significantly higher rates of non-Q-wave myocardial infarction (1.9% vs 5.9%; P: .002), target vessel revascularization (1.9% vs 4.9%; P: .002), coronary artery bypass graft surgery (1.9% vs 6.9%; P: .001), and late stent thrombosis (1.9% vs 3.9%, P: .002).

Conclusions: Patients who received the sirolimus-eluting stent showed better clinical outcomes compared with those who had the paclitaxel-eluting-stent.

Keywords: coronary artery disease, drug-eluting stent, major adverse cardiac event, stent thrombosis.


Citation styles

APA
Çiçek, D., Pekdemir, H., Kalay, N., Binici, S., Altay, H., Müderrisoğlu, H. (2010). Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey. International Journal of Medical Sciences, 7(4), 191-196. https://doi.org/10.7150/ijms.7.191.

ACS
Çiçek, D.; Pekdemir, H.; Kalay, N.; Binici, S.; Altay, H.; Müderrisoğlu, H. Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey. Int. J. Med. Sci. 2010, 7 (4), 191-196. DOI: 10.7150/ijms.7.191.

NLM
Çiçek D, Pekdemir H, Kalay N, Binici S, Altay H, Müderrisoğlu H. Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey. Int J Med Sci 2010; 7(4):191-196. doi:10.7150/ijms.7.191. https://www.medsci.org/v07p0191.htm

CSE
Çiçek D, Pekdemir H, Kalay N, Binici S, Altay H, Müderrisoğlu H. 2010. Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey. Int J Med Sci. 7(4):191-196.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image